Huminsulin N 40IU/ml Injection contains Insulin Isophane (40IU), a long-acting human insulin used in the management of diabetes mellitus to control blood glucose levels. This intermediate-acting insulin is designed to provide a sustained release of insulin, helping to maintain basal insulin levels between meals and overnight. Huminsulin N is indicated for patients requiring insulin therapy to achieve glycemic control when diet, exercise, and oral hypoglycemic agents alone are insufficient. The insulin isophane suspension should be administered subcutaneously, with dosage individualized based on patient needs, blood glucose monitoring, and metabolic requirements. It is essential to rotate injection sites to reduce the risk of lipodystrophy. Huminsulin N may be used alone or in combination with short-acting insulins to optimize blood sugar control. Common adverse effects include hypoglycemia, injection site reactions, and allergic responses. Caution is advised in patients with renal or hepatic impairment, and dose adjustments may be necessary. Patients should be educated on recognizing and managing hypoglycemia and the importance of adherence to prescribed regimens. Huminsulin N should be stored under recommended conditions to maintain potency and efficacy.